/Companies

Restore Vision

Techstars '22

Tokyo, JP · Founded 2016 · 7 employees on LinkedIn · 10 known investors

Find your way into Restore Vision

Sign up to see every warm intro you have to Restore Vision

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Restore Vision team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials. The company develops treatments for ophthalmology and vision-related conditions.

Founders & leadership

Restore Vision was founded in 2016 by Dr. Rajendra S. Apte and Yusaku Katada MD, PhD.

DR
Dr. Rajendra S. AptePaul A. Cibis Distinguished Professor; Vice Chair of Innovation and Translation; Founder
YK
Yusaku Katada MD, PhDCo-founder, Representative Director and CEO/CMO
HMHikaru Miyazaki
Hikaru MiyazakiRepresentative Director and COOHikaru Miyazaki joined the company in 2020 as executive vice president and became representative director in 2023. He previously spent five years as a vice president at the Development Bank of Japan, led the corporate strategy unit at Leave a Nest, co-founded wind turbine startup Challenergy as its executive vice president, and held partner roles at NeuroSpace and tiem factory.

Investors · 10

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Restore Vision do?
Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials. The company develops treatments for ophthalmology and vision-related conditions.
Who founded Restore Vision?
Restore Vision was founded by Dr. Rajendra S. Apte, Yusaku Katada MD, PhD in 2016.
Who are Restore Vision's investors?
Restore Vision's investors include Astellas Venture Management LLC, DBJ Capital, JIC Venture Growth Investments, Kyoto University Innovation Capital, Nippon Venture Capital, OSAKA University Venture Capital, Remiges Ventures, Inc., Spiral Capital and 2 more.
Where is Restore Vision headquartered?
Restore Vision is headquartered in Tokyo, JP.